一项针对美国阿片类药物过量流行病的宏观,中级和微观伤害减轻干预措施的系统审查
Katie A McCormick1,2, Jake Samora1,2, Kasey R Claborn1,2,3
1Steve Hicks School of Social Work, The University of Texas at Austin, 1925 San Jacinto Blvd., Austin, Texas, 78712. U.S.A.
Drugs (Abingdon, England)
|April 10, 2025
概括
减少阿片类药物危害的干预措施在多个层面上显示出有效性. 供应分发方法在增加毒品使用者安全使用知识和行为方面特别有效.
科学领域:
- 公共卫生 公共卫生
- 药物使用研究研究 药物使用研究
- 流行病学 流行病学
背景情况:
- 阿片类药物过量流行需要全面的降低危害策略.
- 干预措施在宏观 (政策),中层 (社区) 和微观 (个人) 层面上实施.
- 了解这些多层次干预措施的有效性至关重要.
研究的目的:
- 为了识别和分类美国的阿片类药物减害干预措施,跨越宏观,中级和微观水平.
- 综合这些干预措施的结果和有效性的证据.
- 突出目前减少危害的方法中的差距.
主要方法:
- 2011-2023年学术文献的系统审查.
- 遵守PRISMA系统审查指南.
- 排除非特定于阿片类药物的研究,缺乏干预效应,或仅专注于治疗阿片类药物使用障碍的医学治疗.
- 两个编码器独立提取数据,并协调差异.
- 提取数据的叙述综合.
主要成果:
- 36项研究符合纳入标准,分为宏观 (n=7),中等 (n=8) 和微观 (n=21) 级别.
- 对微小和中级干预措施的持续积极证据.
- 对宏观层面干预的混合证据.
- 供应分发干预措施在微和中层次上对安全使用知识和行为产生了最显著的影响.
结论:
- 大多数减少危害的干预措施在打击阿片类药物过量流行病方面表现出中等到强烈的有效性.
- 显著缺乏多层次和文化相关的干预措施,特别是在黑人和棕色社区.
- 未来的研究应该专注于综合,文化敏感的减伤策略.
相关概念视频
Drug Abuse and Addiction: Pharmacological Phenomena
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not necessarily...
Opioid Receptors: Overview
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
Analgesia and Pain Management
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Opioid Analgesics: Morphine and Other Natural Cogeners
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
Drug Control Governance: Regulatory Bodies and Their Impact
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with a...


